Bibliography
- DAVIE EW, FUJIKAWA K et al.:Thecoagulationcascade: initiation,maintenance,andregulation.Biochemistry(1991) 30:10363–10370.
- DAS J, KIMBALL SD: Thrombinactivesiteinhibitors.Bioorg. Med. Chem.(1995) 3:999–1007.
- MATSUO T, KARIO K et al.:Clinicalapplicationsofthesynthetic thrombin inhibitor, argatroban (MD-805). Semin. Thromb. Haemost(1992) 18(2):155–160.
- HILPERT K, ACKERMANN J, BANNER DW et al:Designand synthesis of potent and highly selective thrombin inhibitors.JMed. Chem.(1994) 37:3889–5901
- GUSTAFSSON D, ANTONSSON T, BYLUND R et al:Effectsof melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes. Thromb. Haemost.(1998) 79:110–118.
- SALL DJ, BASTIAN JA, BRIGGS SL et al.:Dibasicbenzo[b]thiophene derivatives as a novel class of ac-tive site-directed thrombin inhibitors. 1. Determina-tion of the serine protease selectivity, structure-activity relationships, and binding orienta-tion.JMed. Chem.(1997)40:3489–3493.
- KIM KS, MOQUIN RV, QIAN L et al:Preparationofarga-troban analog thrombin inhibitors with reduced basic guanidine moiety, and studies of their cell permeabil-ityandantithromboticactivities.Med. Chem. Res.(1996) 6:377–383.